Shenzhen Weiguang Biological Products Co., Ltd.

SZSE:002880.SZ

33.35 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012
Revenue 1,048.503667.931907.435904.565821.469687.949623.39566.137500.944452.773355.21300.066
Cost of Revenue 615.259427.024536.523568.218506.133414.328347.175297.838268.009252.028179.89154.997
Gross Profit 433.244240.907370.912336.346315.336273.622276.215268.298232.936200.745175.32145.07
Gross Profit Ratio 0.4130.3610.4090.3720.3840.3980.4430.4740.4650.4430.4940.483
Reseach & Development Expenses 63.61635.86647.58645.09740.16523.70225.62624.77419.77913.77915.46911.936
General & Administrative Expenses 24.68218.01721.1727.99824.69718.05418.71617.10613.98512.10647.30542.988
Selling & Marketing Expenses 40.88527.25423.78519.69124.01924.01214.35312.84512.1611.30311.92211.405
SG&A 65.56645.27244.95547.68948.71642.06633.06929.95126.14523.40859.22754.393
Other Expenses -1.85442.641.3331.54824.4431.3510.50128.33531.10231.3911.0044.448
Operating Expenses 184.102123.738133.87124.333113.32488.03883.71782.3369.61159.08262.50858.543
Operating Income 247.309138.167241.741220.645199.144182178.838168.557139.09111.1193.1779.167
Operating Income Ratio 0.2360.2070.2660.2440.2420.2650.2870.2980.2780.2450.2620.264
Total Other Income Expenses Net -1.854-0.85-0.566-1.604-0.85-3.761-11.714-6.492-17.679-23.817-8.639-3.32
Income Before Tax 245.455137.317241.174219.041198.293181.823180.784179.477145.645117.847104.17483.206
Income Before Tax Ratio 0.2340.2060.2660.2420.2410.2640.290.3170.2910.260.2930.277
Income Tax Expense 27.9116.19736.18229.45627.14225.18626.03526.2520.7917.30515.29311.76
Net Income 218.651117.518205.437190.399171.345156.637154.749153.227124.855100.54288.88171.445
Net Income Ratio 0.2090.1760.2260.210.2090.2280.2480.2710.2490.2220.250.238
EPS 0.960.520.910.840.760.690.780.90.730.590.520.42
EPS Diluted 0.960.520.910.840.760.690.780.90.730.590.520.42
EBITDA 341.646189.464300.58264.367242.332229.456240.37237.737210.898187.998142.609102.52
EBITDA Ratio 0.3260.2840.3310.2920.2950.3340.3860.420.4210.4150.4010.342